Host Immune & Vasculature Systems

The Host Immune & Vasculature Systems represent a complex physiological network rather than a single molecular target. This category encompasses the dynamic interactions between the host's immune cells and the endothelial lining of the blood vessels, which together regulate inflammation, nutrient transport, and tissue repair (Pober & Sessa, Nature Reviews Immunology, 2007). In pathological conditions such as sepsis, severe viral infections like COVID-19, and malignancy, the dysregulation of this interface leads to systemic inflammatory response syndrome (SIRS), vascular leakage, and coagulopathy (Teuwen et al., Nature Reviews Immunology, 2020). Drugs targeting this system typically act on specific signaling molecules like Vascular Endothelial Growth Factor (VEGF) or Interleukin-6 (IL-6) to restore vascular integrity or dampen hyper-inflammation (Tanaka et al., Cold Spring Harbor Perspectives in Biology, 2014). Because it involves multiple cell types and signaling pathways, it is classified as a systemic physiological target rather than a discrete protein (Carmeliet, Nature, 2005). Understanding this crosstalk is vital for developing therapies that balance effective immune defense with the prevention of vascular-mediated organ damage (Mantovani et al., Nature, 2008).

Other names

Immune-Vascular InterfaceHost Defense and Circulatory SystemsNeuro-Immune-Vascular interactions

Modulation of systemic inflammatory cascades, inhibition of angiogenic growth factors, stabilization of vascular endothelium, and regulation of leukocyte extravasation.